Kronos Bio Inc (KRON) — Financial Flexibility Index
Kronos Bio Inc (KRON) has a Financial Flexibility Index of -0.45x as of March 2025. Free cash flow of $-12.84 Million (operating CF $-12.84 Million minus capex $4.00K) represents 0% of total liabilities ($28.33 Million). Also explore Kronos Bio Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kronos Bio Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Kronos Bio Inc across 7 annual periods. Check KRON capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Kronos Bio Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Kronos Bio Inc. For the full company profile including market capitalisation, see KRON company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.78x | $-65.43 Million | $-65.44 Million | $36.78 Million | ▼ -23.8% |
| 2023 | -1.44x | $-77.90 Million | $-78.58 Million | $54.20 Million | ▲ +19.8% |
| 2022 | -1.79x | $-90.35 Million | $-90.93 Million | $50.44 Million | ▲ +26.9% |
| 2021 | -2.45x | $-113.66 Million | $-117.92 Million | $46.38 Million | ▼ -301.6% |
| 2020 | -0.61x | $-28.34 Million | $-37.91 Million | $46.45 Million | ▼ -533.1% |
| 2019 | -0.10x | $-12.13 Million | $-15.08 Million | $125.89 Million | ▲ +64.2% |
| 2018 | -0.27x | $-5.37 Million | $-6.44 Million | $19.91 Million | — |